Skip to content
LexBuild

Healthcare Infection Control Practices Advisory Committee (HICPAC); Cancellation of Meeting

---
identifier: "/us/fr/2020-10417"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Healthcare Infection Control Practices Advisory Committee (HICPAC); Cancellation of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2020-10417"
section_name: "Healthcare Infection Control Practices Advisory Committee (HICPAC); Cancellation of Meeting"
positive_law: false
currency: "2020-05-15"
last_updated: "2020-05-15"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2020-10417"
document_type: "notice"
publication_date: "2020-05-15"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "85 FR 29454"
fr_volume: 85
docket_ids:
  - "Docket No. CDC-2020-0047"
---

#  Healthcare Infection Control Practices Advisory Committee (HICPAC); Cancellation of Meeting

Notice is hereby given of a change in the meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC); [Docket No. CDC-2020-0047]; May 15, 2020, 3:00 p.m. to 4:30 p.m., EDT, which was published in the *Federal Register* on April 30, 2020, Volume 85, Number 84, pages 23965-23966.

This meeting is being canceled in its entirety.

**FOR FURTHER INFORMATION CONTACT:**

Koo-Whang Chung, M.P.H., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, MS H16-3, Atlanta, Georgia 30329-4027; Telephone: 404-639-4000; Email: *[email protected].*

The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: May 11, 2020.

Kalwant Smagh,

Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.